Ted Mathias serves as lead counsel in complex patent litigation, often managing cases involving more than 15 patents. He frequently handles matters at the intersection of patent and antitrust law, with a strong focus on advising clients in the pharmaceutical industry.
Recognized as an intellectual property “Litigation Star” by Benchmark Litigation and one of 500 Leading Litigators in America by Lawdragon, Ted represents clients in district courts nationwide and before the U.S. Court of Appeals for the Federal Circuit. He brings extensive experience in representing both patent owners and accused infringers in cases involving pharmaceuticals, medical devices, mechanical devices, e-commerce, and software. His practice also covers complex litigation involving antitrust claims arising from patent disputes, standards setting, patent pooling, IP licensing issues, and sham suits.
Ted notably served as lead counsel for a client in a landmark case, becoming the first to survive summary judgment on a claim involving exclusionary rebating practices in the pharmaceutical industry. With deep expertise in patent remedies, he was a key member of the Axinn team that defended a $1.4 billion claim for a pharmaceutical client, which settled after a two-week trial. He also achieved a significant victory in a trade secrets case, successfully defending an $800 million claim and securing summary judgment of no lost profits.
In addition to his trial work, Ted represents clients in private dispute resolution proceedings, mediations, and government investigations concerning antitrust, unfair competition, false advertising, and internet privacy issues.
Ted serves as Chair of the American Bar Association Section of Intellectual Property Law’s (ABA-IPL) Section 102/103 Subcommittee. Ted’s commitment to pro bono work includes defending prisoners’ rights in multiple cases, including class action litigations.
Updated Sep 2025
